227 related articles for article (PubMed ID: 17827739)
61. Inositol Hexaphosphate and Inositol Inhibit Colorectal Cancer Metastasis to the Liver in BALB/c Mice.
Fu M; Song Y; Wen Z; Lu X; Cui L
Nutrients; 2016 May; 8(5):. PubMed ID: 27187454
[TBL] [Abstract][Full Text] [Related]
62. Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model.
Tao L; Yang JK; Gu Y; Zhou X; Zhao AG; Zheng J; Zhu YJ
World J Gastroenterol; 2015 Jan; 21(4):1125-39. PubMed ID: 25632185
[TBL] [Abstract][Full Text] [Related]
63. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer.
Cunningham D; Pyrhönen S; James RD; Punt CJ; Hickish TF; Heikkila R; Johannesen TB; Starkhammar H; Topham CA; Awad L; Jacques C; Herait P
Lancet; 1998 Oct; 352(9138):1413-8. PubMed ID: 9807987
[TBL] [Abstract][Full Text] [Related]
64. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.
Rougier P; Van Cutsem E; Bajetta E; Niederle N; Possinger K; Labianca R; Navarro M; Morant R; Bleiberg H; Wils J; Awad L; Herait P; Jacques C
Lancet; 1998 Oct; 352(9138):1407-12. PubMed ID: 9807986
[TBL] [Abstract][Full Text] [Related]
65. [Inhibitory effects of CPT-11 on liver metastases in nude mice injected with human pancreatic tumor cells into their spleens].
Takeda S; Kono A
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2433-6. PubMed ID: 2260878
[No Abstract] [Full Text] [Related]
66. Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study.
Behr TM; Salib AL; Liersch T; Béhé M; Angerstein C; Blumenthal RD; Fayyazi A; Sharkey RM; Ringe B; Becker H; Wörmann B; Hiddemann W; Goldenberg DM; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3232s-3242s. PubMed ID: 10541369
[TBL] [Abstract][Full Text] [Related]
67. Pentoxifylline promotes development of murine colon adenocarcinoma-derived metastatic tumors in liver.
Grzela T; Lazarczyk M; Niderla J; Golab J; Lazarczyk MA; Skopinski P
Oncol Rep; 2003; 10(6):1805-9. PubMed ID: 14534700
[TBL] [Abstract][Full Text] [Related]
68. Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study.
Liang YH; Shao YY; Chen HM; Cheng AL; Lai MS; Yeh KH
Anticancer Res; 2017 Dec; 37(12):7095-7104. PubMed ID: 29187501
[TBL] [Abstract][Full Text] [Related]
69. Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.
Houghton JA; Cheshire PJ; Hallman JD; Lutz L; Luo X; Li Y; Houghton PJ
Clin Cancer Res; 1996 Jan; 2(1):107-18. PubMed ID: 9816097
[TBL] [Abstract][Full Text] [Related]
70. [Drug clinics. How I treat. II. Therapeutic approaches to metastatic colorectal cancer].
Jerusalem G; Bours V; Fillet G
Rev Med Liege; 1998 Jun; 53(6):318-21. PubMed ID: 9713208
[TBL] [Abstract][Full Text] [Related]
71. Efficacy of oncolytic herpesvirus NV1020 can be enhanced by combination with chemotherapeutics in colon carcinoma cells.
Gutermann A; Mayer E; von Dehn-Rothfelser K; Breidenstein C; Weber M; Muench M; Gungor D; Suehnel J; Moebius U; Lechmann M
Hum Gene Ther; 2006 Dec; 17(12):1241-53. PubMed ID: 17117895
[TBL] [Abstract][Full Text] [Related]
72. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A
Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608
[TBL] [Abstract][Full Text] [Related]
73. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
[TBL] [Abstract][Full Text] [Related]
74. [A case of unresectable multiple hepatic metastases from ascending colon cancer successfully treated with panitumumab and FOLFIRI(5-FU/LV/irinotecan)therapy].
Yoshida R; Matsuura T; Hijikawa K; Yanagida H; Kitade H; Takada H; Kwon AH
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1575-7. PubMed ID: 23064076
[TBL] [Abstract][Full Text] [Related]
75. Experimental cancer chemotherapy using a liver metastatic model of human colon cancer transplanted into the spleen of severe combined immunodeficient mice.
Kuo TH; Kubota T; Nishibori H; Watanabe M; Furukawa T; Kase S; Tanino H; Saikawa Y; Teramoto T; Kitajima M
J Surg Oncol; 1993 Feb; 52(2):92-6. PubMed ID: 8468978
[TBL] [Abstract][Full Text] [Related]
76. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
[TBL] [Abstract][Full Text] [Related]
77. Novel experimental models of human cancer metastasis in nude mice: lung metastasis, intraabdominal carcinomatosis with ascites, and liver metastasis.
Naomoto Y; Kondo H; Tanaka N; Orita K
J Cancer Res Clin Oncol; 1987; 113(6):544-9. PubMed ID: 3680363
[TBL] [Abstract][Full Text] [Related]
78. Early tumor growth in metastatic organs influenced by the microenvironment is an important factor which provides organ specificity of colon cancer metastasis.
Hara Y; Ogata Y; Shirouzu K
J Exp Clin Cancer Res; 2000 Dec; 19(4):497-504. PubMed ID: 11277329
[TBL] [Abstract][Full Text] [Related]
79. Interaction of fibronectin with human colon adenocarcinoma cells: effect on the in vivo tumorigenic capacity.
López-Conejo MT; Olmo N; Turnay J; López De Silanes I; Lizarbe MA
Oncology; 2002; 62(4):371-80. PubMed ID: 12138246
[TBL] [Abstract][Full Text] [Related]
80. Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.
Allen WL; Johnston PG
Pharmacogenomics; 2005 Sep; 6(6):603-14. PubMed ID: 16143000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
